Clinical Trial Update: Efficacy and Safety of IBI362 in Hypertensive Patients With Overweight/Obesity [Phase 3]

View source ↗

Summary

This update describes a Phase 3 trial evaluating the efficacy and safety of IBI362 in hypertensive patients with overweight/obesity and notes that the study is …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypertension
• Obesity

Drugs mentioned

• IBI362

Snippet

Sponsor: Innovent Biologics (Suzhou) Co. Ltd. | Conditions: Overweight, Obesity | Phase 3 | Status: NOT_YET_RECRUITING